Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mi Wang

Showing results (521-530 of 545) with videos related to

Pageof 55
Sort By:
BMC Psychiatry|July 30, 2025
Depression and anxiety symptoms associated with internet addiction and non-suicidal self-injury in Chinese adolescent students - a network analysisMohan Ma, Chuman Xiao, Wenwen Ou, et al.
Journal of Medicinal Chemistry|January 2, 2025
Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.
Journal of Diabetes Research|December 29, 2023
A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter StudyYuetong Zhao, Lin Liu, Li Zuo, et al.
Neuroimage|March 28, 2025
Altered brain network dynamics during rumination in remitted depressionSu Shu, Wenwen Ou, Mohan Ma, et al.
Journal of Molecular Biology|January 10, 2019
Changing the Apoptosis Pathway through Evolutionary Protein DesignDavid Shultis, Pralay Mitra, Xiaoqiang Huang, et al.
Neuroimage. Clinical|September 23, 2025
Brain network dynamics during rumination relate to relapse of depressionSu Shu, Yumeng Ju, Mi Wang, et al.
Journal of Medicinal Chemistry|June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm DevelopmentRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry|June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerXin Han, Lijie Zhao, Weiguo Xiang, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of Potent, Highly Selective, and Efficacious SMARCA2 DegradersZhenwu Li, Lalgudi S Harikrishnan, Guozhang Xu, et al.
Pageof 55

Showing results (521-530 of 545) with videos related to

Sort By:
Pageof 55
BMC Psychiatry|July 30, 2025
Depression and anxiety symptoms associated with internet addiction and non-suicidal self-injury in Chinese adolescent students - a network analysisMohan Ma, Chuman Xiao, Wenwen Ou, et al.
Journal of Medicinal Chemistry|January 2, 2025
Discovery of SMD-3236: A Potent, Highly Selective and Efficacious SMARCA2 Degrader for the Treatment of SMARC4-Deficient Human CancersLin Yang, Wenbin Tu, Lingying Leng, et al.
Journal of Diabetes Research|December 29, 2023
A Novel Risk Score Model for the Differential Diagnosis of Type 2 Diabetic Nephropathy: A Multicenter StudyYuetong Zhao, Lin Liu, Li Zuo, et al.
Neuroimage|March 28, 2025
Altered brain network dynamics during rumination in remitted depressionSu Shu, Wenwen Ou, Mohan Ma, et al.
Journal of Molecular Biology|January 10, 2019
Changing the Apoptosis Pathway through Evolutionary Protein DesignDavid Shultis, Pralay Mitra, Xiaoqiang Huang, et al.
Neuroimage. Clinical|September 23, 2025
Brain network dynamics during rumination relate to relapse of depressionSu Shu, Yumeng Ju, Mi Wang, et al.
Journal of Medicinal Chemistry|June 26, 2020
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm DevelopmentRohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry|June 29, 2023
Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate CancerXin Han, Lijie Zhao, Weiguo Xiang, et al.
Journal of Medicinal Chemistry|July 18, 2018
Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorYujun Zhao, Bing Zhou, Longchuan Bai, et al.
Journal of Medicinal Chemistry|November 21, 2024
Discovery of Potent, Highly Selective, and Efficacious SMARCA2 DegradersZhenwu Li, Lalgudi S Harikrishnan, Guozhang Xu, et al.
Pageof 55